These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14584071)

  • 1. K-ras mutation in tamoxifen-related endometrial polyps.
    Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
    Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
    Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.
    Fujiwara K; Enomoto T; Fujita M; Kanda T; Fujii S; Ito K; Wakasa K; Ishiko O; Ueda M; Yamaguchi S; Kimura T; Umesaki N
    Oncol Rep; 2008 May; 19(5):1293-8. PubMed ID: 18425390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
    Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
    Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
    Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
    J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.
    Tsujioka H; Hachisuga T; Hikita S; Ueda T; Yotsumoto F; Shirota K; Yoshizato T; Kawarabayashi T; Kuroki M; Miyamoto S
    Anticancer Res; 2010 Aug; 30(8):3119-23. PubMed ID: 20871029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
    Sant'Ana de Almeida EC; Nogueira AA; Candido dos Reis FJ; Zambelli Ramalho LN; Zucoloto S
    Maturitas; 2004 Nov; 49(3):229-33. PubMed ID: 15488351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamoxifen and giant endometrial polyps].
    Caschetto S; Cassaro N; Consalvo P; Caragliano L
    Minerva Ginecol; 2000 Nov; 52(11):459-63. PubMed ID: 11256174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial.
    Duffy SR; Taylor L
    Am J Obstet Gynecol; 2004 Dec; 191(6):1921-7. PubMed ID: 15592273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
    Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
    Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen.
    McGurgan P; Taylor LJ; Duffy SR; O'Donovan PJ
    Maturitas; 2006 Jun; 54(3):252-9. PubMed ID: 16413707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.
    Tsujioka H; Hachisuga T; Fukuoka M; Ueda T; Miyahara D; Horiuchi S; Shirota K; Yoshizato T; Emoto M; Miyamoto S; Kawarabayashi T
    Int J Gynecol Cancer; 2009 Aug; 19(6):1052-6. PubMed ID: 19820367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.